Hyperfine Investor Presentation Deck
Clinical Proof: Twenty-five Peer-Reviewed Publications to Date and
Significant Investment in Studies in New Clinical Use Cases
American Journal of Neuroradiology, April 2022
Implementation of a Low-Field Portable MRI Scanner in a Resource-
Constrained Environment: Our Experience in Malawi
Acquired >260 brain scans; concluded use may lead to faster diagnosis and
expedited treatment, including in comatose patients in the E.D. and bed-bound
patients with sudden onset neurologic deficits
Science Advances, April 2022
Portable, Low-Field MRI Enables Highly Accessible and Dynamic
Bedside Evaluation of Ischemic Stroke
Imaged 50 confirmed acute ischemic stroke patients; accurately detected
infarcts in 45 (90%) ; captured lesions as small as 4mm
Nature Communications, August 2021
Portable, Bedside, Low-Field Magnetic Resonance Imaging for
Evaluation of Intracerebral Hemorrhage
Imaged >140 patients and correctly identified ICH in over 80% of confirmed cases
14
PROPERTY OF HYPERFINE, INC. ©2023. All rights reserved.
Key Observational Studies Pursuing
Multiple Clinical Applications
ACTION PMR (Stroke)
• HOPE PMR (Hydrocephalus)
• SAFE MRI (ECMO)
●
Presented initial findings at Asia-Pacific
Extracorporeal Life Support Organization
(APELSO) Meeting in November 2023
HYPERFINEⓇView entire presentation